Updates are available Correction dated 2025-03-24
Click to view Correction: https://doi.org/10.1038/s41598-025-93618-w
-
Authors
Wiedemann, Anna
Stochl, Jan
Neufeld, Sharon A. S.
Fritz, Jessica
Bhatti, Junaid
Hook, Roxanne W.
,
Bullmore, Edward
Dolan, Raymond
Goodyer, Ian
Fonagy, Peter
Jones, Peter
Moutoussis, Michael
Hauser, Tobias
Neufeld, Sharon
Romero-Garcia, Rafael
Clair, Michelle St.
Vértes, Petra
Whitaker, Kirstie
Inkster, Becky
Prabhu, Gita
Ooi, Cinly
Toseeb, Umar
Widmer, Barry
Bhatti, Junaid
Villis, Laura
Alrumaithi, Ayesha
Birt, Sarah
Bowler, Aislinn
Cleridou, Kalia
Dadabhoy, Hina
Davies, Emma
Firkins, Ashlyn
Granville, Sian
Harding, Elizabeth
Hopkins, Alexandra
Isaacs, Daniel
King, Janchai
Kokorikou, Danae
Maurice, Christina
McIntosh, Cleo
Memarzia, Jessica
Mills, Harriet
O’Donnell, Ciara
Pantaleone, Sara
Scott, Jenny
Kiddle, Beatrice
Polek, Ela
Fearon, Pasco
Suckling, John
van Harmelen, Anne-Laura
Kievit, Rogier
Chamberlain, Sam
Bethlehem, Richard A. I.
Goodyer, Ian M.
Dolan, Raymond J.
Bullmore, Edward T.
Chamberlain, Samuel R.
Fonagy, Peter
Perez, Jesus
Jones, Peter B.
-
Funding
Funding for this research was provided by:
NIHR ARC East of England
NIHR Cambridge Bioresource
Wellcome Trust
- License Information
-
More Information
Article History
Received: 25 March 2022
Accepted: 22 September 2022
First Online: 5 October 2022
Change Date: 24 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-025-93618-w
Competing interests
: ETB serves on the scientific advisory board of Sosei Heptares and as a consultant for GlaxoSmithKline and Monument Therapeutics. SRC receives honoraria from Elsevier for editorial work outside of the submitted work. Previously, he also consulted for Promentis. All other authors declare no competing interests.
